LATEST UPDATES » Vol 25, No. 09, September 2021 – The Rise of Alternative Proteins       » The Key to Improving Iron Content in Crops       » Breeding Non-GMO Plants With Next-Generation Chloroplast Gene-Editing       » New Lipomer Can Now Safely Deliver RNA Drugs to Lungs       » Preventing Deadly Post-Transplant Infection With Llama Nanobodies       » Insulin-Producing Implants: The Future of Care for Type 1 Diabetes      
Vol 25, No. 08, August 2021   |   Issue PDF view/purchase
The Role of China in Future Epidemics
China has done well in infection control since the early part of the COVID-19 pandemic. Apart from the strict, rather drastic measures of isolation, containment, and restrictions, there is a general belief that the integrative use of Traditional Chinese Medicine has helped to give better treatment outcomes.

The use of integrated treatment has been endorsed and guided on a national level and supported by the general public. Experts recommended specific choices of herbal formulae to be used at different stages of infection -- mild, moderate, and severe.

Historical accounts on the clinical effectiveness of herbal medicine to infections are plentiful in China, particularly for respiratory infections. In the past decades, many widespread influenza epidemics in China have involved extensive uses of Traditional Chinese Medicine with many apparent merits. For example, the recent SARS crisis of 2003 saw 60 per cent of infected patients in China receiving Chinese Medicine treatment. Subsequent analysis of the clinical value revealed the remarkable efficacies of its supportive role on fever, cough, and other symptomatic control.


To read the full article, please feel free to:

Purchase the full issue at SGD 26.00
Subscribe to Asia-Pacific Biotech News Magazine
news TechInnovation 2021 Virtual Exhibition to Showcase Sustainable Energy, Food, and Healthcare Solutions
news A New Approach for Effective Gout Treatment
news TechInnovation Returns from 28 to 30 September 2021
news Singapore Health & Biomedical Congress 2021 is Set to Brave the New Frontiers as We Revolutionise and Transform Healthcare

About Us
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen Chan
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
Copyright© 2021 World Scientific Publishing Co Pte Ltd  •  Privacy Policy